Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equine Hyperimmune Serum for Hospitalized COVID-19
NCT04913779Phase 3Unknown
- Start
- Jun 2021
- Primary completion
- Nov 2021
- Modality
- Antibody Conjugates, scFv Fragments, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of equine immunoglobulin anti SARS-CoV-2 in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
equine immunoglobulin anti SARS-CoV-2
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04913779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04913779.